BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23519518)

  • 1. Intraperitoneal cytokine level in patients with peritoneal surface malignancies. A study of the RENAPE (French Network for Rare Peritoneal Malignancies).
    Vlaeminck-Guillem V; Bienvenu J; Isaac S; Grangier B; Golfier F; Passot G; Bakrin N; Rodriguez-Lafrasse C; Gilly FN; Glehen O
    Ann Surg Oncol; 2013 Aug; 20(8):2655-62. PubMed ID: 23519518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudomyxoma peritonei: inflammatory responses in the peritoneal microenvironment.
    Lohani K; Shetty S; Sharma P; Govindarajan V; Thomas P; Loggie B
    Ann Surg Oncol; 2014 May; 21(5):1441-7. PubMed ID: 24046117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
    McKenney JK; Soslow RA; Longacre TA
    Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritoneal fluid cytokines and sICAM-1 in minimal endometriosis: search for discriminating factors between infertility and/or endometriosis.
    Skrzypczak J; Szczepańska M; Puk E; Kamieniczna M; Kurpisz M
    Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):95-103. PubMed ID: 16154044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of complete cytoreductive surgery and two intraperitoneal chemotherapy techniques in Pseudomyxoma peritonei.
    Sørensen O; Flatmark K; Reed W; Wiig JN; Dueland S; Giercksky KE; Larsen SG
    Eur J Surg Oncol; 2012 Oct; 38(10):969-76. PubMed ID: 22763244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I study of intraperitoneal recombinant human interleukin 12 in patients with Müllerian carcinoma, gastrointestinal primary malignancies, and mesothelioma.
    Lenzi R; Rosenblum M; Verschraegen C; Kudelka AP; Kavanagh JJ; Hicks ME; Lang EA; Nash MA; Levy LB; Garcia ME; Platsoucas CD; Abbruzzese JL; Freedman RS
    Clin Cancer Res; 2002 Dec; 8(12):3686-95. PubMed ID: 12473577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraperitoneal cytokine response after major surgery: higher postoperative intraperitoneal versus systemic cytokine levels suggest the gastrointestinal tract as the major source of the postoperative inflammatory reaction.
    Jansson K; Redler B; Truedsson L; Magnuson A; Matthiessen P; Andersson M; Norgren L
    Am J Surg; 2004 Mar; 187(3):372-7. PubMed ID: 15006565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum and peritoneal fluid concentrations of soluble human leukocyte antigen, tumor necrosis factor alpha and interleukin 10 in patients with selected ovarian pathologies.
    Sipak-Szmigiel O; Włodarski P; Ronin-Walknowska E; Niedzielski A; Karakiewicz B; Słuczanowska-Głąbowska S; Laszczyńska M; Malinowski W
    J Ovarian Res; 2017 Apr; 10(1):25. PubMed ID: 28376925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritoneal cytokines predict mortality after surgical treatment of secondary peritonitis in the rat.
    Hendriks T; Bleichrodt RP; Lomme RM; De Man BM; van Goor H; Buyne OR
    J Am Coll Surg; 2010 Aug; 211(2):263-70. PubMed ID: 20670866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome.
    Sugarbaker PH
    Eur J Surg Oncol; 2001 Apr; 27(3):239-43. PubMed ID: 11373099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D; Kusamura S; Nonaka D; Langer M; Andreola S; Favaro M; Gavazzi C; Laterza B; Deraco M
    Ann Surg Oncol; 2008 Feb; 15(2):526-34. PubMed ID: 18043976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment serum levels of cytokines and cytokine receptors in patients with non-small cell lung cancer, and correlations with clinicopathological features and prognosis. M-CSF - an independent prognostic factor.
    Kaminska J; Kowalska M; Kotowicz B; Fuksiewicz M; Glogowski M; Wojcik E; Chechlinska M; Steffen J
    Oncology; 2006; 70(2):115-25. PubMed ID: 16645324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathologic analysis in 46 patients with pseudomyxoma peritonei syndrome: failure versus success with a second-look operation.
    Yan H; Pestieau SR; Shmookler BM; Sugarbaker PH
    Mod Pathol; 2001 Mar; 14(3):164-71. PubMed ID: 11266521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An exploratory study of inflammatory cytokines as prognostic biomarkers in patients with ductal pancreatic adenocarcinoma.
    Dima SO; Tanase C; Albulescu R; Herlea V; Chivu-Economescu M; Purnichescu-Purtan R; Dumitrascu T; Duda DG; Popescu I
    Pancreas; 2012 Oct; 41(7):1001-7. PubMed ID: 22722257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of peritoneal carcinomatosis from colonic cancer by cytoreduction, peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC). Experience of ten years.
    Vaira M; Cioppa T; D'Amico S; de Marco G; D'Alessandro M; Fiorentini G; De Simone M
    In Vivo; 2010; 24(1):79-84. PubMed ID: 20133981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
    Vaira M; Cioppa T; DE Marco G; Bing C; D'Amico S; D'Alessandro M; Fiorentini G; DE Simone M
    In Vivo; 2009; 23(4):639-44. PubMed ID: 19567401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Baratti D; Kusamura S; Martinetti A; Seregni E; Laterza B; Oliva DG; Deraco M
    Ann Surg Oncol; 2007 Aug; 14(8):2300-8. PubMed ID: 17510772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MUC2 is a molecular marker for pseudomyxoma peritonei.
    O'Connell JT; Hacker CM; Barsky SH
    Mod Pathol; 2002 Sep; 15(9):958-72. PubMed ID: 12218214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritonitis in childhood: clinical relevance of cytokines in the peritoneal exudate.
    Haecker FM; Fasler-Kan E; Manasse C; Fowler B; Hertel R; von Schweinitz D
    Eur J Pediatr Surg; 2006 Apr; 16(2):94-9. PubMed ID: 16685614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritoneal inflammation and fatigue experiences following colorectal surgery: a pilot study.
    Paddison JS; Booth RJ; Fuchs D; Hill AG
    Psychoneuroendocrinology; 2008 May; 33(4):446-54. PubMed ID: 18258374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.